Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2013 2
2014 3
2016 2
2017 3
2018 2
2019 3
2020 4
2021 3
2022 5
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
SEOM-GECOD clinical guideline for unknown primary cancer (2021).
Losa F, Fernández I, Etxaniz O, Giménez A, Gomila P, Iglesias L, Longo F, Nogales E, Sánchez A, Soler G. Losa F, et al. Among authors: etxaniz o. Clin Transl Oncol. 2022 Apr;24(4):681-692. doi: 10.1007/s12094-022-02806-x. Epub 2022 Mar 23. Clin Transl Oncol. 2022. PMID: 35320504 Free PMC article.
Applications of genomics in NSCLC.
Rosell R, Cobo M, Isla D, Sanchez JM, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniz O. Rosell R, et al. Among authors: etxaniz o. Lung Cancer. 2005 Dec;50 Suppl 2:S33-40. Lung Cancer. 2005. PMID: 16557672 Review.
Customized procedure to display T-Scan occlusal contacts.
Solaberrieta E, Etxaniz O, Otegi JR, Brizuela A, Pradies G. Solaberrieta E, et al. Among authors: etxaniz o. J Prosthet Dent. 2017 Jan;117(1):18-21. doi: 10.1016/j.prosdent.2016.07.006. Epub 2016 Jul 28. J Prosthet Dent. 2017. PMID: 27475919
Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.
Fernández O, Lázaro-Quintela M, Crespo G, Soto de Prado D, Pinto Á, Basterretxea L, Gómez de Liaño A, Etxaniz O, Blasco S, Gabás-Rivera C, Aceituno S, Palomar V, Polanco-Sánchez C. Fernández O, et al. Among authors: etxaniz o. Front Oncol. 2022 Jan 7;11:773366. doi: 10.3389/fonc.2021.773366. eCollection 2021. Front Oncol. 2022. PMID: 35070976 Free PMC article.
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy.
Pardo JC, Sanhueza T, Ruiz de Porras V, Etxaniz O, Rodriguez H, Martinez-Cardús A, Grande E, Castellano D, Climent MA, Lobato T, Estudillo L, Jordà M, Carrato C, Font A. Pardo JC, et al. Among authors: etxaniz o. J Clin Med. 2022 Jan 19;11(3):497. doi: 10.3390/jcm11030497. J Clin Med. 2022. PMID: 35159947 Free PMC article.
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Font A, Domenech M, Buisan O, Lopez H, González A, Etxaniz O, Matas M, Elias X, Gomez M, Figols M, Horneros J, Pardo JC, Notario L, Ruiz de Porras V, Perez I, Areal J, Esteve A. Font A, et al. Among authors: etxaniz o. World J Urol. 2022 Nov;40(11):2627-2634. doi: 10.1007/s00345-022-04147-4. Epub 2022 Sep 15. World J Urol. 2022. PMID: 36107212
29 results